Demystifying Ocular Syphilis - A Major Review.
Khushboo ChauhanAlex FonollosaLena GiraltJoseba ArtarazEdward L RandersonDebra A GoldsteinJoão M FurtadoJustine R SmithSridharan SudharshanArshee S AhmedNivedita NairJoveeta JosephCarlos PavesioMark WestcottSupawat TrepatchayakornAhmed B SallamAbdelrahman M ElhusseinyMudit TyagiPublished in: Ocular immunology and inflammation (2023)
Syphilis, caused by the spirochaete, Treponema pallidum, continues to be a public health challenge globally with its rates steadily increasing in the past few years. The disease is transmitted through small breaks in the skin during sexual contact, or via congenital transmission in utero, either across the placenta or by contact with an active genital lesion during delivery. Estimated 5.7-6 million new cases are detected every year worldwide in the 15-49 years age group. An increased incidence has been reported in most populations with particular clusters in special groups like men who have sex with men, female sex workers, and their male clients. Ocular syphilis has a varied presentation and is considered a great mimicker in all cases of uveitis. The laboratory diagnosis of syphilis is predominantly based on serological tests including TPHA and VDRL. Parenteral penicillin is the cornerstone of treatment for all stages of ocular syphilis.
Keyphrases
- men who have sex with men
- hiv testing
- hiv positive
- public health
- human immunodeficiency virus
- risk factors
- juvenile idiopathic arthritis
- optic nerve
- mental health
- rheumatoid arthritis
- south africa
- wound healing
- african american
- replacement therapy
- hepatitis c virus
- disease activity
- optical coherence tomography
- soft tissue